Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Probiotics are believed to alleviate allergic and inflammatory skin disorders, but their impact on pathogenic effector T cells remains poorly documented. Here we show that oral treatment with the probiotic bacteria L. casei (DN-114 001) alone alleviates antigen-specific skin inflammation mediated by either protein-specific CD4(+) T cells or hapten-specific CD8(+) T cells. In the model of CD8(+) T cell-mediated skin inflammation, which reproduces allergic contact dermatitis in human, inhibition of skin inflammation by L. casei is not due to impaired priming of hapten-specific IFNgamma-producing cytolytic CD8(+) effector T cells. Alternatively, L. casei treatment reduces the recruitment of CD8(+) effector T cells into the skin during the elicitation (i.e. symptomatic) phase of CHS. Inhibition of skin inflammation by L. casei requires MHC class II-restricted CD4(+) T cells but not CD1d-restricted NK-T cells. L casei treatment enhanced the frequency of FoxP3(+) Treg in the skin and increased the production of IL-10 by CD4(+)CD25(+) regulatory T cells in skin draining lymph nodes of hapten-sensitized mice. These data demonstrate that orally administered L. casei (DN-114 001) efficiently alleviate T cell-mediated skin inflammation without causing immune suppression, via mechanisms that include control of CD8(+) effector T cells and involve regulatory CD4(+) T cells. L. casei (DN-114 001) may thus represent a probiotic of potential interest for immunomodulation of T cell-mediated allergic skin diseases in human.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 1×
“It is possible that components of the bacteria circulating via the blood flow or via lymph may reach gut-draining and non draining lymphoid organs [32], exert their effect on Agpresenting DC [33,34].”
BackgroundCD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Nancey, S., Holvöet, S., Graber, I., Joubert, G., Philippe, D., Martin, S., Nicolas, J., Desreumaux, P., Flourié, B., & Kaiserlian, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.018 · Cited by 112
Self-citation
Cited by
The gut microbiome as a major regulator of the gut-skin axis
Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01459 · Cited by 707
Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris
O’Neill, A. M., & Gallo, R. L. (2018) · Microbiome · doi:10.1186/s40168-018-0558-5 · Cited by 334
The Skin Microbiome: A New Actor in Inflammatory Acne
Dréno, B., Dagnelie, M. A., Khammari, A., & Corvec, S. (2020) · American Journal of Clinical Dermatology · doi:10.1007/s40257-020-00531-1 · Cited by 317
Potential Role of the Microbiome in Acne: A Comprehensive Review
Lee, Y. B., Byun, E. J., & Kim, H. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070987 · Cited by 316
Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?
Bowe, W. P., & Logan, A. C. (2011) · Gut Pathogens · doi:10.1186/1757-4749-3-1 · Cited by 292
Metadata
- Authors
- Hacini-Rachinel, F., Gheit, H., Le Luduec, J.-B., Dif, F., Nancey, S., & Kaiserlian, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-03-20
- Volume
- 4
- Issue
- 3
- Pages
- e4903
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2018393721
- Cited by
- 131
- References
- 2
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.